Literature DB >> 19387472

Genome-wide linkage analysis of serum creatinine in three isolated European populations.

Cristian Pattaro1, Yurii S Aulchenko, Aaron Isaacs, Veronique Vitart, Caroline Hayward, Christopher S Franklin, Ozren Polasek, Ivana Kolcic, Zrinka Biloglav, Susan Campbell, Nick Hastie, Gordan Lauc, Thomas Meitinger, Ben A Oostra, Ulf Gyllensten, James F Wilson, Irene Pichler, Andrew A Hicks, Harry Campbell, Alan F Wright, Igor Rudan, Cornelia M van Duijn, Peter Riegler, Fabio Marroni, Peter P Pramstaller.   

Abstract

There is increasing evidence for a role of genetic predisposition in the etiology of kidney disease, but linkage scans have been poorly replicated. Here we performed a genome-wide linkage analysis of serum creatinine on 2859 individuals from isolated villages in South Tyrol (Italy), Rucphen (The Netherlands) and Vis Island (Croatia), populations that have been stable and permanently resident in their region. Linkage of serum creatinine levels to loci on chromosomes 7p14, 9p21, 11p15, 15q15-21, 16p13, and 18p11 was successfully replicated in at least one discovery population or in the pooled analysis. A novel locus was found on chromosome 10p11. Linkage to chromosome 22q13, independent of diabetes and hypertension, was detected over a region containing the non-muscle myosin heavy chain type II isoform A (MYH9) gene (LOD score=3.52). In non-diabetic individuals, serum creatinine was associated with this gene in two of the three populations and in meta-analysis (SNP rs11089788, P-value=0.0089). In populations sharing a homogeneous environment and genetic background, heritability of serum creatinine was higher than in outbred populations, with consequent detection of a larger number of loci than reported before. Our finding of a replicated association of serum creatinine with the MYH9 gene, recently linked to pathological renal conditions in African Americans, suggests that this gene may also influence kidney function in healthy Europeans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387472     DOI: 10.1038/ki.2009.135

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  42 in total

1.  The new era of APOL1-associated glomerulosclerosis.

Authors:  Barry I Freedman; Carl D Langefeld
Journal:  Nephrol Dial Transplant       Date:  2012-02-02       Impact factor: 5.992

2.  Translating associations between common kidney diseases and genetic variation into the clinic.

Authors:  Paul E Drawz; John R Sedor
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 3.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

4.  Glomerular MYH9 expression is reduced by HIV-1.

Authors:  Thomas Hays; Vivette D D'Agati; Jonathan A Garellek; Tjani Warren; Marc E Trubin; Deborah P Hyink; John Cijiang He; Paul E Klotman
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

Review 5.  Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Semin Dial       Date:  2010-05-10       Impact factor: 3.455

Review 6.  Insights into the genetic architecture of diabetic nephropathy.

Authors:  Nicholette D Palmer; Barry I Freedman
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 7.  Susceptibility genes in common complex kidney disease.

Authors:  Jasmin Divers; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

8.  Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals.

Authors:  Iris M Heid; Peter Henneman; Andrew Hicks; Stefan Coassin; Thomas Winkler; Yurii S Aulchenko; Christian Fuchsberger; Kijoung Song; Marie-France Hivert; Dawn M Waterworth; Nicholas J Timpson; J Brent Richards; John R B Perry; Toshiko Tanaka; Najaf Amin; Barbara Kollerits; Irene Pichler; Ben A Oostra; Barbara Thorand; Rune R Frants; Thomas Illig; Josée Dupuis; Beate Glaser; Tim Spector; Jack Guralnik; Josephine M Egan; Jose C Florez; David M Evans; Nicole Soranzo; Stefania Bandinelli; Olga D Carlson; Timothy M Frayling; Keith Burling; George Davey Smith; Vincent Mooser; Luigi Ferrucci; James B Meigs; Peter Vollenweider; Ko Willems van Dijk; Peter Pramstaller; Florian Kronenberg; Cornelia M van Duijn
Journal:  Atherosclerosis       Date:  2009-12-02       Impact factor: 5.162

Review 9.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

Review 10.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.